John Sperzel
Chief Executive Officer chez T2 BIOSYSTEMS, INC.
Fortune : 2 016 $ au 29/02/2024
Profil
John J.
Sperzel is a businessperson who has been at the head of 6 different companies and currently holds the position of Chairman, President & Chief Executive Officer of T2 Biosystems, Inc. He is also on the board of Ontera, Inc.
In the past John J.
Sperzel held the position of President, Chief Executive Officer & Director at Chembio Diagnostics, Inc., President, CEO & Independent Director at Chembio Diagnostics, Inc., Chief Executive Officer for ITC Nexus Holding Co., Inc., President, Chief Executive Officer & Director at Chembio Diagnostic Systems, Inc., President & Chief Executive Officer of International Technidyne Corp., President-USA at Axis-Shield Ltd., Vice President for Roche Diagnostics Corp.
and President-Marketing & Business Development at Bayer Diagnostics Corp.
John J.
Sperzel received an undergraduate degree from Plymouth State University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
T2 BIOSYSTEMS, INC.
0,01% | 01/03/2024 | 400 ( 0,01% ) | 2 016 $ | 29/02/2024 |
Postes actifs de John Sperzel
Sociétés | Poste | Début |
---|---|---|
T2 BIOSYSTEMS, INC. | Chief Executive Officer | 08/01/2020 |
Anciens postes connus de John Sperzel
Sociétés | Poste | Fin |
---|---|---|
CHEMBIO DIAGNOSTICS, INC. | Chief Executive Officer | 09/01/2020 |
CHEMBIO DIAGNOSTICS, INC. | Chief Executive Officer | 30/05/2017 |
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Chief Executive Officer | 01/12/2013 |
International Technidyne Corp.
International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Chief Executive Officer | 01/12/2013 |
AXIS-SHIELD LTD | Corporate Officer/Principal | - |
Formation de John Sperzel
Plymouth State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
T2 BIOSYSTEMS, INC. | Health Technology |
Entreprise privées | 9 |
---|---|
Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostics, Inc. engages in the developing, manufacturing, marketing, and licensing of rapid medical tests. It offers rapid point-of-care tests for infectious, tropical and fever, and respiratory diseases, handheld analyzers, and veterinary products. The firm distributes its products to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
Bayer Diagnostics Corp. | Health Technology |
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Health Technology |
Axis-Shield Ltd.
Axis-Shield Ltd. Medical SpecialtiesHealth Technology Axis-Shield Ltd. operates as a biotechnology company. The company was founded 1993 and is headquartered in the United Kingdom. | Health Technology |
Chembio Diagnostic Systems, Inc.
Chembio Diagnostic Systems, Inc. Medical SpecialtiesHealth Technology Chembio Diagnostic Systems, Inc. engages in the development, manufacture, and commercialization of point-of-care diagnostic tests and technology for the detection of infectious diseases. It offers human and veterinary diagnostic products. The company was founded in 1985 and is headquartered in Medford, NY. | Health Technology |
International Technidyne Corp.
International Technidyne Corp. Medical SpecialtiesHealth Technology International Technidyne Corp. manufactures point of care hemostasis management products. Its products include HEMOCRON, IRMA TRUpoint, AVOXimeter, ProTime, HgbPro, tenderfool, Tenderleft, and Surigicutt. The company was founded in 1969 and is headquartered in Edison, NJ. | Health Technology |
Roche Diagnostics Corp.
Roche Diagnostics Corp. Medical SpecialtiesHealth Technology Roche Diagnostics Corp. develops and manufactures diagnostic products. It offers anticoagulation management, blood gas and electrolytes, cholesterol and urinalysis products. The firm provides a broad portfolio of tools that help healthcare providers in the prevention, diagnosis and management of diseases like HPV, HIV, heart failure and diabetes, as well as other medical conditions, such as fertility and blood coagulation. Its products and services uses by researchers, physicians, patients, hospitals and laboratories worldwide. The company was founded in 1964 by Willard Eason and is headquartered in Indianapolis, IN. | Health Technology |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Ontera, Inc.
Ontera, Inc. Medical SpecialtiesHealth Technology Ontera, Inc. operates as a biotechnology company which develops single molecule biosensors for diagnostic uses. Its products include sample prep, amplification, measurement, analysis and applications. The firm is a creator of a tiny device that enables detection of any molecule of interest, including nucleic acids, proteins, metabolites, drugs and small molecules. The company was founded by Dan Heller, William Dunbar and Trevor Morin and is headquartered in Santa Cruz, CA. | Health Technology |